Commission on European Affairs
The Commission on European Affairs (CEA) is elected by the European ILAE Chapters; its goal is to stimulate and co-ordinate all activities related to epilepsy and epileptology across Europe, in compliance with ILAE directives.
CEA is responsible for organising the official regional ILAE Congress (European Congress of Epileptology).
The CEA supports Educational activities across Europe (for Guidelines and Application Form visit the Reports Section) and promotes initiatives for the development of research and care in the field of epilepsy.
A list of CEA supported educational activities can be found in the Meetings & Courses section of this site.
Direct access to individual chapters websites can be obtained in the Chapters section.
The European Commission offers an opportunity to have a concrete influence on the direction of EU research policies by inviting those interested to apply to the High Level Group on maximizing the impact of EU Research and Innovation programmes. This presents a genuine opportunity for the brain space to get actively involved in shaping not only the evaluation of Horizon 2020, but also the direction of the H2020 successor — the shape of the next EU Framework Programme will be closely related to the evaluation of H2020. Application deadline 9 September
Testing patients during seizures: A European consensus procedure developed by a joint taskforce of the ILAE – Commission on European Affairs and the European Epilepsy Monitoring Unit Association (2016)
Interview with Meir Bialer and Sándor Beniczky
EAN Interview by Prof. David B. Vodušek, May 4, 2016
European Study on the Burden and Care of Epilepsy (ESBACE)
ESBACE is a pan-European research project to facilitate the development of high-quality epilepsy care at all stages of the disease, equitable across EU countries. ESBACE will provide data on the burden of epilepsy and on current provision
and organization of care in selected EU member states as well as a comparison of the standards of care. Funding is being secured from the European Commission for this research project.
ESBACE’s first objective is to
define appropriate standard methods for a population-based study
of prevalence, cost and stigma of epilepsy, and also to survey
organization and quality of epilepsy care.
ESBACE objectives, methods and means, and expected outcomes
Use of valproate in women and girls
Letter to the EMA (European Medicines Agency) from the ILAE Commission on European Affairs (CEA), ILAE Commission on Medical Therapies, and ILAE Task Force on AED Trials and Regulatory Affaiwrs regarding PRAC recommendations to strengthen the restrictions on the use of valproate in women and girls. ILAE Letter | EMA PRAC Recommendation
Recommendations from a joint Task Force of ILAE - Commission on European Affairs and European Academy of Neurology (EAN) (2015):
Guideline | Português